Loading
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (52 ops.)
Latest filing published 30 Apr 2026 for Silver Point Specialty Lending Fund, €2.1M.
Filing timeline
BuySaleUniversity of Texas/Texas AM Investment Management Co
Insider track record
Disclosed buys
7
Disclosed sells
52
Signal history
Closed purchases
Market purchases
7
Positive at T+90
40%
Median T+90
-8.1%
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -8.1%Entry 0.04 · Close at T+90 0.03
- +6.5%Entry 0.04 · Close at T+90 0.04
- -54.1%Entry 0.07 · Close at T+90 0.03
- -56.5%Entry 0.09 · Close at T+90 0.04
- +165.3%Entry 0.04 · Close at T+90 0.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
University of Texas/Texas AM Investment Management Co: trading record in brief
Filings by University of Texas/Texas AM Investment Management Co span 2 companies, the busiest being Rein Therapeutics, Inc. and Silver Point Specialty Lending Fund. In total, 59 filings cover trades dated from 29 April 2024 to 1 April 2026.
The open-market side counts 7 purchases for €26.6M alongside 52 sales for €342k. The totals exclude 2 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2026, the count stands at 4 purchases and no sales.
A typical purchase (the median) is worth €5.8M. Across 5 purchases, this insider has always bought alone, with no colleague buying within 30 days. After 5 purchases with a full 90-day history, the hit rate stands at 40% and the median 90-day move at -8.1%. This is a record of the past, not a forecast.
The latest filing, published on 30 April 2026, reports an open-market purchase of €2.1M in Silver Point Specialty Lending Fund. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 13 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to University of Texas/Texas AM Investment Management Co
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
86,674.641 shares@ US$27.477.7% of flowCOMMON SHARESSEC:0001019231-26-000014:0
Canonical exit: 30 Jun 2026 (T+90)
170,984.013 shares@ US$27.8515.2% of flowCOMMON SHARESSEC:0001019231-26-000013:0
Canonical exit: 31 May 2026 (T+90)
245,231.474 shares@ US$27.9321.7% of flowCOMMON SHARESSEC:0001019231-26-000012:0
Canonical exit: 3 May 2026 (T+90)
347,236.69 shares@ US$27.9631.1% of flowCOMMON SHARESSEC:0001019231-26-000001:0
Canonical exit: 2 Apr 2026 (T+90)
609,115.652 shares@ €12.170917.8% of flowCOMMON SHARESSEC:0001019231-25-000013:0
Canonical exit: 1 Mar 2026 (T+90)
622,251.721 shares@ €12.253218.3% of flowCOMMON SHARESSEC:0001019231-25-000012:0
Canonical exit: 30 Jan 2026 (T+90)
534,633.563 shares@ US$14.1724.3% of flowCommon StockSEC:0001193125-25-251957:0
Canonical exit: 30 Dec 2025 (T+90)
1,900 shares@ US$3.306.0% of flowCommon StockSEC:0001019231-24-000026:0
9,577 shares@ US$3.3030.3% of flowCommon StockSEC:0001019231-24-000025:0
6,291 shares@ US$3.3019.7% of flowCommon StockSEC:0001019231-24-000024:0
3,100 shares@ US$4.1012.2% of flowCommon StockSEC:0001019231-24-000023:0
6,680 shares@ US$4.9231.7% of flowCommon StockSEC:0001019231-24-000022:0
12 of 12 declarations
